about
Role of Myofibrillar Protein Catabolism in Development of Glucocorticoid Myopathy: Aging and Functional Activity AspectsSarcopenia and the analysis of body composition.Are we closer to having drugs to treat muscle wasting disease?Skeletal muscle measures and physical function in older adults with cancer: sarcopenia or myopenia?Quantitative ultrasound: measurement considerations for the assessment of muscular dystrophy and sarcopenia.Efforts begin to sprout: publications in JCSM on cachexia, sarcopenia and muscle wasting receive attention.Sarcopenia with limited mobility: an international consensus.Recent developments in the treatment of cachexia: highlights from the 6th Cachexia Conference.Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology.The epidemiology of sarcopenia in community living older adults: what role does lifestyle play?The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cBody composition, muscle strength and hormonal status in patients with ataxia telangiectasia: a cohort study.Consilience in sarcopenia of cirrhosis.Serological muscle loss biomarkers: an overview of current concepts and future possibilitiesSkeletal Muscle Changes After Elective Colorectal Cancer Resection: A Longitudinal Study.Loss of oxidative defense and potential blockade of satellite cell maturation in the skeletal muscle of patients with cancer but not in the healthy elderly.Sarcopenia in the elderly.Muscle atrophy in aging and chronic diseases: is it sarcopenia or cachexia?Omega-3 fatty acids and changes in LBM: alone or in synergy for better muscle health?Sarcopenia in solid organ transplantation.Muscle wasting disease: a proposal for a new disease classification.Cachexia: clinical features when inflammation drives malnutrition.The wasting continuum in heart failure: from sarcopenia to cachexia.Cachexia in patients with oesophageal cancer.Nutrition Screening vs Nutrition Assessment: What's the Difference?Influence of body composition profile on outcomes following colorectal cancer surgery.Sarcopenia, as defined by low muscle mass, strength and physical performance, predicts complications after surgery for colorectal cancer.Moving upwards - the journal of cachexia, sarcopenia and muscle in 2016.Searching for a relevant definition of sarcopenia: results from the cross-sectional EPIDOS study.Weight Loss Strategies in the Elderly: A Clinical Conundrum.Relationship between the Mediterranean dietary pattern and musculoskeletal health in children, adolescents, and adults: systematic review and evidence map.Body Composition as a Predictor of Toxicity in Patients Receiving Anthracycline and Taxane-Based Chemotherapy for Early-Stage Breast Cancer.Myopenia and precision (P4) medicine.Obesity Interventions for Older Adults: Diet as a Determinant of Physical Function.More variety with the Journal of Cachexia, Sarcopenia and Muscle: JCSM Clinical Reports and JCSM Rapid Communications have both gone live.Low skeletal muscle mass as a risk factor for postoperative delirium in elderly patients undergoing colorectal cancer surgery
P2860
Q26748922-B5D1949E-A7CA-4A4A-BDA2-C36D71369EBAQ33578662-F46476EC-0AF6-4FA7-A484-D3B3271A5481Q33741103-113E92EC-D7C7-4207-9CA1-DBBF49984B46Q33779613-A9015646-5734-46DB-B3E7-FEB3F9F9E0F0Q33891261-AFA3CFC2-D606-4E92-85E9-915D5E3A0A2EQ34156932-49D4C4EB-2FCB-4E2B-8490-E9D993C05414Q34189767-4B595189-0E43-4514-99DF-F1815CD2C943Q34264508-E3FAAA44-A0CA-4A97-942E-1EAB1F6A21FFQ34334313-63502CBD-CA1F-4A9F-8DF1-D965DE7D509DQ35223989-E32EA573-6520-4C94-8BAC-18B9ED6301D4Q35569473-7EEC1CCA-D10F-4A5E-B694-D9C51E831DD7Q36357809-F6C87B85-ADFC-4770-9663-4583EE2D5047Q36421047-A7823FB4-9C77-407B-8918-5D43DE2E5E22Q36636397-C0BA50F8-8ECC-4304-8DA4-AEAA3E7697C6Q37053402-92822E25-C424-4F52-8FE1-0DA9A498B9D3Q37274976-25DBE5C7-3BC3-413F-8F67-A3A56A2FE255Q37991671-C515DE5F-477F-4409-B866-F2B859D1E36AQ38024726-AA1D6DF8-E18F-4078-A3BE-212FCDB2D5BCQ38112812-44D81BED-0A34-4641-9716-882CEBD9C7D6Q38188425-ADE63975-8B8B-46B8-AB82-B2DC098CA393Q38268470-DA36D6F9-6E0D-4DBA-9DF2-171ACCF9A0BBQ38391442-E07501F4-0585-49ED-A235-EDDC63DE94D4Q38564746-A2E08013-6EE0-4AEE-BE42-4D5AC762F2A6Q38634739-2B77FEBD-7268-4A3A-A4F6-27F214CA4B66Q39447884-4B180E6B-1B92-4B55-9E65-4EE40A17D34FQ39905178-957FF10A-44EC-4BEE-90B8-26BD764A7049Q41098906-D2ED67EF-1C5A-45B7-A327-252084A7665BQ42398018-6CDD5023-064D-41D4-8188-C3A9D9704E5FQ42944295-6EE49598-E15F-4920-A83F-6AA927290B68Q47173336-55358591-1EC2-4E4D-B983-CBEC6A2BEE74Q47803194-3A75EBD9-BC90-40D5-B468-279FAC23F439Q49195380-5A2ED909-6067-4CBF-89E7-C30FB4D8F91BQ49859737-AA96A433-EF64-4A96-9305-F783A04804FAQ52586030-ECD7BB36-1BA5-4F17-8832-23C20DD0A018Q52806155-3723F3DC-B7F8-48B4-81FE-27266D954D6DQ58698617-EFA2CFA4-3899-4EA3-802A-879E7411BFFB
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Myopenia-a new universal term for muscle wasting
@ast
Myopenia-a new universal term for muscle wasting
@en
Myopenia-a new universal term for muscle wasting
@nl
type
label
Myopenia-a new universal term for muscle wasting
@ast
Myopenia-a new universal term for muscle wasting
@en
Myopenia-a new universal term for muscle wasting
@nl
prefLabel
Myopenia-a new universal term for muscle wasting
@ast
Myopenia-a new universal term for muscle wasting
@en
Myopenia-a new universal term for muscle wasting
@nl
P2860
P3181
P1476
Myopenia-a new universal term for muscle wasting
@en
P2093
Kenneth Fearon
William J Evans
P2860
P2888
P3181
P356
10.1007/S13539-011-0025-7
P407
P577
2011-03-01T00:00:00Z
P5875
P6179
1032937291